Visualization of superparamagnetic nanoparticles in vascular tissue using XμCT and histology

Histochemistry and Cell Biology

Volumn 135, Issue 2, 2011, Pages 153-158

  Tietze, Rainer ^a   Rahn, Helene ^b   Lyer, Stefan ^a   Schreiber, Eveline ^a   Mann, Jenny ^a   Odenbach, Stefan ^b   Alexiou, Christoph ^a  

^a Section for Experimental Oncology and Nanomedicine   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Cancer therapy; Histology; Magnetic drug targeting; Nanoparticles; X CT

Indexed keywords

FERRIC FERROCYANIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANIMAL CELL; ANIMAL TISSUE; ARTERY; ARTICLE; CONTROLLED STUDY; COW; CROSS-SECTIONAL STUDY; EX VIVO STUDY; HISTOLOGY; IN VIVO STUDY; MAGNETIC FIELD; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; PRIORITY JOURNAL; SIMULATION; THREE DIMENSIONAL IMAGING; TISSUE DISTRIBUTION; VASCULAR TISSUE; X RAY ANALYSIS;

ARTERIES; DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; FERROCYANIDES; MAGNETICS; NANOPARTICLES; X-RAY MICROTOMOGRAPHY;

BOVINAE;

EID: 79951720591     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00418-011-0780-8     Document Type: Article

References (15)

1. C Alexiou W Arnold RJ Klein FG Parak P Hulin C Bergemann W Erhardt S Wagenpfeil AS Lubbe 2000 Locoregional cancer treatment with magnetic drug targeting Cancer Res 60 6641 6648 1:CAS:528:DC%2BD3cXosl2isbc%3D 11118047
2. C Alexiou R Jurgons RJ Schmid C Bergemann J Henke W Erhardt E Huenges F Parak 2003 Magnetic drug targeting-biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment J Drug Target 11 139 149 1:CAS:528:DC%2BD3sXntFCmtLY%3D 10.3109/ 1061186031000150791 13129824 (Pubitemid 37236327)
3. C Alexiou D Diehl P Henninger H Iro R Rockelein W Schmidt H Weber 2006 A high field gradient magnet for magnetic drug targeting IEEE Trans Appl Supercond 16 1527 1530 10.1109/TASC.2005.864457 (Pubitemid 44150135)
4. C Alexiou RJ Schmid R Jurgons M Kremer G Wanner C Bergemann E Huenges T Nawroth W Arnold FG Parak 2006 Targeting cancer cells: magnetic nanoparticles as drug carriers Eur Biophys J Biophys Lett 35 446 450 1:CAS:528: DC%2BD28XjvFGitb4%3D
5. R Asmatulu MA Zalich RO Claus JS Riffle 2005 Synthesis, characterization and targeting of biodegradable magnetic nanocomposite particles by external magnetic fields J Magn Magn Mater 292 108 119 1:CAS:528:DC%2BD2MXjtF2mtL4%3D 10.1016/j.jmmm.2004.10.103 (Pubitemid 40423107)
6. O Brunke S Odenbach R Jurgons C Alexiou I Hilger F Beckmann 2006 Determination of the magnetic particle distribution in tumour tissue by means of X-ray tomography J Phys Condens Matter 18 S2903 S2917 1:CAS:528: DC%2BD28XhtFelsr%2FL 10.1088/0953-8984/18/38/S25 (Pubitemid 44523009)
7. JM Collins 1984 Pharmacological rationale for regional drug delivery J Clin Oncol 2 498 505 1:STN:280:DyaL2c3hsFahug%3D%3D 6547166
8. Häfeli U (2001) Magneto-and radio-pharmaceuticals, radioactive magnetic microspheres. In: Arshady R, Guyot A (eds) Microspheres microcapsules and liposomes. Citus, London, pp 559-584
9. SE Khalafalla GW Reimers 1980 Preparation of dilution-stable aqueous magnetic fluids IEEE Trans Magn 16 178 183 10.1109/TMAG.1980.1060578
10. T Neuberger B Schopf H Hofmann M Hofmann B von Rechenberg 2005 Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system J Magn Magn Mater 293 483 496 1:CAS:528:DC%2BD2MXktVagsbo%3D 10.1016/j.jmmm.2005.01.064 (Pubitemid 40608969)
11. H Rahn I Gomez-Morilla R Jurgons C Alexiou S Odenbach 2008 Microcomputed tomography analysis of ferrofluids used for cancer treatment J Phys Condens Matter 20 204152 204156 10.1088/0953-8984/20/20/204152 (Pubitemid 351640993)
12. C Seliger R Jurgons F Wiekhorst D Eberbeck L Trahms H Iro C Alexiou 2007 In vitro investigation of the behaviour of magnetic particles by a circulating artery model J Magn Magn Mater 311 358 362 1:CAS:528:DC%2BD2sXjtVeitb0%3D 10.1016/j.jmmm.2006.10.1205 (Pubitemid 46401046)
13. G Storm SO Belliot T Daemen DD Lasic 1995 Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system Adv Drug Deliver Rev 17 31 48 1:CAS:528:DyaK2MXps1Wltbk%3D 10.1016/0169-409X(95)00039-A
14. M Taupitz S Wagner B Hamm D Dienemann R Lawaczeck KJ Wolf 1993 MR lymphography using iron oxide particles. Detection of lymph node metastases in the VX2 rabbit tumour model Acta Radiol 34 10 15 1:STN:280:DyaK3s7lt1egtg%3D%3D 8427741 (Pubitemid 23079350)
15. VP Torchilin 2000 Drug targeting Eur J Pharm Sci 11 S81 S91 1:CAS:528:DC%2BD3cXntF2gtbc%3D 10.1016/S0928-0987(00)00166-4 11033430